Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VDAC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KLF7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | MLH3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GLS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DARS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF501 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AGTRAP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TRIM9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ANKRD36C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | EIF6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |